• 500mg/2ml solution for injection 
• GWH only. For treatment of Acanthamoeba keratitis.
• Non formulary at RUH and SFT

• 5% eye drops
• 5% preservative-free eyedrops (GWH only)

• 1% eye ointment 
• RUH only. Non formulary at GWH and SFT

• 0.3% eye drops
  
  
•  Salisbury
•  RUH and GWH - For corneal crystallisation and endophthalmitis
  

• 0.5% eye ointment
• GWH only for suspected chlamydia in neonates on the advice of paediatrician
• Non formulary at RUH and SFT

• 1% eye drops

Fusidic acid eye drops are no longer included in primary care guidance for the management of bacterial conjunctivitis due to high cost (£29.06 per 5g May 2019) and poor activity for a self-limiting condition. 

Use should be restricted to people who:
- Are pregnant
- Have a personal or family history of blood dyscrasias, such as aplastic anaemia
- Are intolerant of chloramphenicol
- Need a twice-a-day treatment for infective conjunctivitis
See CKS topic for more information

• 0.3% eye drops

• - GWH.
• Non-formulary - SFT & RUH.
• 1.5 % preservative-free eye drops.

• 5mg/ml eye drops
  
  
•  Salisbury
•  BaNES and Swindon

• 400mg tablets 
• GWH only - For the treatment of endophthalmitis, 400mg OD for 10 days.
• Non formulary at RUH and SFT

• 0.3% eye drops
  
  
• in BaNES and Swindon
•  in Salisbury

• 5000 units in 1ml eye drops
• GWH only. Non formulary at RUH and SFT

• 0.02% eye drops
• GWH and RUH only. Non formulary at SFT

• 0.1% eye drops
• 0.15% ointment
• GWH only. Non formulary at RUH and SFT

• GWH only. For intravitreal injection
• Non formulary at RUH and SFT

• GWH only - Only for treatment of fungal endophthalmitis after consultant or senior ophthalmologist approval. See information sheet for dilution instructions.
• Non formulary at RUH and SFT

• 0.15% eye gel
  
  
• in Salisbury
•  in Swindon and BaNES - ONLY for patients with corneal stromal herpes simplex keratitis, aciclovir-resistant herpes simplex keratitis & herpetic keratouveitis on the advice of a Consultant ophthalmologist

• 0.1% eye drops

• Betamethasone sodium phosphate 0.1% with Neomycin sulfate 0.5% eye drops 

• 0.1% eye drops

• - Bath & Swindon
• Non formulary - Salisbury
• 0.1% preservative free eye drops in 0.5ml unit doses

• 700 micrograms intravitreal implant in applicator
• For the treatment of adults with macular oedema following either branch retinal vein occlusion or central retinal vein occlusion ONLY in line with local commissioning criteria and NICE TA229.
• For the treatment of patients with sight problems caused  diabetic macular oedema, in line with NICE TA349.
• For the treatment of patients with non-infectious uveitis, in line with NICE TA460. Only available in specialist centres (not RUH or SFT).

• Dexamethasone 1 mg/gram with neomycin 3500 units/gram and polymyxin B sulfate 6000 unit per 1 gram in 3.5g eye ointment
• Dexamethasone 1 mg/ml with hypromellose 5 mg/ml with neomycin (as neomycin sulfate) 3500 units/ml with polymyxin B sulfate 6000 units/ml in 5ml eye drops

• Dexamethasone 1 mg/ml with tobramycin 3 mg/ml eye drops.
• Salisbury only
• Non formulary in BaNES and Swindon

• For the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy. In line with NICE TA301 Nov 2013.  Patients need to have gained 10 or more ETDRS letters of visual acuity between baseline and month 36 to receive a further implant at month 36 according to NICE TA301.
• Note: concurrent treatment to both eyes not recommended (SPC).
• A single implant releases fluocinolone for up to 36 months.
• Implantation may not be repeated more frequently than every 36 months due to lack of evidence base of benefit.

• 0.1% ophthalmic solution

• 3.35mg/ml eye drops 0.4ml unit dose

• Salisbury only
• Non formulary at RUH and GWH

• 0.5% ophthalmic drops, 1% ophthalmic drops
• Preservative free available if indicated

• 0.1% and 0.3% ophthalmic drops  NOTE STRENGTHS
• GWH only - For use in herpes simplex keratitis only
• These strengths are non formulary at RUH and Salisbury

• 2% ophthalmic drops
• If issuing FP10, ensure that prescriptions are written for 13.5ml, not 10ml or ‘1op’ as these preparations are ‘over-the-counter’ products and are more expensive.

• 1mg/1ml ophthalmic drops.

• - Salisbury & Swindon - 2nd-line after Olopatidine.
• Non formulary - Bath.
• 0.25mg/ml single dose unit drops SPC here.

• 1% ophthalmic drops

• 1% single use minims

• 0.5% and 1% ophthalmic drops
• 0.5% and 1% minims

• 0.5% and 1%

• RUH and Salisbury only
• Non formulary at GWH

• Phenylephrine 2.5% and 10% eyedrops
• GWH only - Phenylephrine 1% injection for consultant/senior ophthalmologist approval

• 0.5% ophthalmic drops and 0.25% ophthalmic solution

• BaNES and Swindon
• Non formulary in Salisbury
• 2.5mg/ml and 5mg/ml preservative free ophthalmic drops

•   - Swindon
• Non formulary- Bath & Salisbury
• 0.1 % ophthalmic gel

• 300micrograms and 5mg/ml combination ophthalmic drops

• Latanoprost 50micrograms, Timolol 5mg/ml
• Note: Fixapost^® preservative free included on formulary at SFT 

• 40microgram ophthalmic drops

• 40microgram with 5mg/ml Timolol ophthalmic drops

• 100microgram/ml ophthalmic drops
• 300microgram/ml preservative free single use eyedrops available where indicated as per BSW glaucoma guidance

• 0.2% ophthalmic eye drops
• Note - higher risk of side-effects and sensitivity.

• Brinzolamide 1% with Timolol 0.5% 

•  BaNES and Salisbury for glaucoma
•  Swindon for glaucoma
• 250mg tablets and 250mg MR capsules (NB capsules more costly and stock shortages until at least July 2020)
• Note: at RUH and GWH, acetazolamide is included on the formulary for idiopathic intracranial hypertension as Unlicensed indication
• Note - Private prescription only for prophylaxis of mountain sickness. Not licensed and NOT for prescribing on NHS. For further information see link below 

• 500mg injection

• 1% eye drops

• ophthalmic drops containing 10 mg/mL of brinzolamide and 2 mg/mL of brimonidine tartrate equivalent to 1.3 mg of brimonidine.

BaNES/Wilts - For use as per Glaucoma guidance 
Swindon - Not on formulary

• 2% eye drops

• 5ml ophthalmic drops

• 2% and 4% eyedrops.
• 2% preservative-free minims (Swindon only).

• 0.5ml unit dose.

• 0.4% single use drops

• at RUH
•  in Salisbury and Swindon
• 0.5% single use drops

• 0.5% and 1% single use drops

• 1,500unit powder for solution for injection ampoules
• adjunct to local anaesthesia in ophthalmology

• 0.2% drops 10ml (Hydramed^®)
• 0.4% drops 10ml (Viz-Hyal^®)
• Preservative-free
• To be prescribed in line with BSW Dry Eye Guidance. 

• Acetylcysteine eye drops 5%, hypromellose 0.35% 10ml (includes benzalkonium chloride, disodium edetate)
• Specialist initiation - Only if filamentary keratitis present.

• Carmellose 0.5ml, glycerol 1%, castor oil 0.25% 10ml

• 0.1% drops (1 mg/mL eye drops, emulsion)
• Note - Ensure correct product is prescribed; available products have different licensing information and TLS. 
• Ikervis ® is licensed for the treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
• Verkazia®  is licensed for the treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents. See here

• GWH for recurrent erosions only. Not on formulary at RUH/SFT
• Consider Hylo-night (formerly VitA-POS or Hydramed night)

• 10ml

• 10ml

• 5g Preservative-free ointment

Better known by brand names:

- Hydramed Night® (Retinol palmitate 250iu/g, liquid paraffin, white soft paraffin, wool fat) 5g (PF) 3/12 expiry

- VitA-POS® (Retinol palmitate 250iu/g, liquid paraffin, wool fat) 5g (PF) 6/12 expiry NOTE from April 2020, VitA-POS is rebranding as HYLO NIGHT. The ointment ingredients and composition remaining the same as VitA-POS.

• Eye irrigation solutions 19ml, 500ml

• 0.9% 0.5ml Preservative-free

• 0.9% drops

Sodium chloride 5% (preserved) eyedrops for patients with corneal oedema or corneal erosions on the advice of a Consultant Ophthalmologist. In primary care these should be prescribed as Hypersal 5% eyedrops or Sodium Chloride 5% eyedrops (Alissa®) as other unlicensed products are prohibitively expensive.

Sodium Chloride 5% PF eye ointment for patients with corneal oedema or corneal erosions, unable to tolerate preserved drops, on the advice of a Consultant Ophthalmologist. In primary care these should be prescribed as Sodium Chloride 5% PF eye ointment (Alissa®) as other unlicensed products are prohibitively expensive.

Please note - Sodium Chloride 5% eye products not on formulary at SFT

• 0.1% Preservative-free (VisuXL^®)
• 2 month expiry
• Specialist initiation only in line with BSW dry eye guidance 

• 0.2% eye ointment - Unlicensed preparation
• GWH only - ONLY for patients who respond to ciclosporin but fail to tolerate Ikervis presentation. Only to be prescribed on yellow GWH hospital outpatient prescription and NOT FP10
• Non formulary in RUH and SFT

• For use within GWH only

• 20mg powder and solvent for solution for intraocular irrigation

• 1% single use eye drops 
  

   

•  3mg in 0.3ml pre-prepared injection.
•  50mg vial.

•  Swindon - Pre-operative & immediately post - operatively. For short-term pain relief in episcleritis, cornial abrasion or foreign bodies. Avoid single use except in allergy to preservatives
• RUH (Single use eye drops 0.1%)
• Non formulary in Salisbury

• 1% and 2% minims
• Ophthalmic strips
• GWH only
• Non formulary at RUH and Salisbury

• 0.5% ophthalmic drops
• Note at GWH - For inflammation requiring extended treatment (up to 21 days) following ocular surgery

• Salisbury only
• Non formulary in BaNES and Swindon

•  - GWH - For use in Ophthalmology.
•  Non-formulary- SFT & RUH.
•  5ml vial.

•   - GWH - For use in Ophthalmology.
•  Non-formulary - SFT & RUH

GWH Eye Theatre Use Only During Post COVID-19

• Intracameral injection
• Added to formulary for 6 months during post COVID-19 (review date Jan 21)

• 0.37% eyedrop Unlicensed
• RUH and GWH - for chelation of cornea for calcific band keratopathy.
• Not on formulary at SFT

• Swindon only - used in theatre intra-operatively (trabeculectomy) and for needling of trabeculectomy post-op. Special chemotherapeutic agent manufactured for individual patients. 48 hours notice required. Consultant ophthalmologist prescription only.
• For licensed indications for fluorouracil see chapter 8.1.3 and chapter 13.8.1(topical)
• Non formulary at RUH and SFT